Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Anna Pasetto
Introduction
Anna Pasetto is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of cancer research, holding a total of six patents. Her work focuses on developing T cell receptors that target specific mutations associated with cancer, showcasing her dedication to advancing medical science.
Latest Patents
Among her latest patents is the development of HLA class II-restricted T cell receptors against the RAS with G12R mutation. This patent discloses an isolated or purified T cell receptor (TCR) that has antigenic specificity for a mutated human RAS amino acid sequence. The TCR specifically targets the substitution of glycine at position 12 with arginine. Additionally, the patent includes related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. It also outlines methods for detecting cancer in mammals and approaches for treating or preventing cancer.
Another significant patent involves T cell receptors recognizing mutated P53. This patent describes an isolated or purified T cell receptor (TCR) that has antigenic specificity for mutated human p53. Similar to her previous patent, it includes related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. It also provides methods for detecting the presence of cancer in mammals and strategies for treatment or prevention.
Career Highlights
Anna Pasetto is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to contribute to groundbreaking research in immunotherapy and cancer treatment.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including Steven A. Rosenberg and Yong-Chen Lu. These partnerships have further enhanced her research and innovation in the field of cancer immunology.
Conclusion
Anna Pasetto's innovative work in developing T cell receptors for cancer treatment exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches in oncology.